|
|||||
|
|
COVID-19-neutralizing antibodies predict disease severity and survival |
|
| Authors: | Wilfredo F. Garcia-Beltran Evan C. Lam Michael G. Astudillo Diane Yang Tyler E. Miller Jared Feldman Blake M. Hauser Timothy M. Caradonna Kiera L. Clayton Adam D. Nitido Mandakolathur R. Murali Galit Alter Richelle C. Charles Anand Dighe John A. Branda Jochen K. Lennerz Daniel Lingwood Aaron G. Schmidt Alejandro B. Balazs |
| Affiliation: | 1. Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA;2. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA;3. Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA;4. Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02114, USA |
| Abstract: |  |
| Keywords: | COVID-19 SARS-CoV-2 ELISA RBD spike neutralizing antibodies disease severity pro-inflammatory cytokines D614G WIV1-CoV |
| 本文献已被 ScienceDirect 等数据库收录！ | |